TCT 4: Rationale and Design of the IMODERN STOP-IMH Randomized Trial: The Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for STEMI and the Effect on Intramyocardial Haemorrhage
We Recommend
Disclosures
NULL
New at TCTMD? Register today!
Enter the email you used to register to reset your password.